Tag:
Menactra
Latest Headlines
Latest Headlines
FDA clears Menactra for infants
The FDA has expanded the indication of Sanofi-Aventis' Menactra to include a two-dose schedule for infants and children 9 months through 23 months of age, marking the first time a meningococcal
Vax panel votes to add meningitis booster dose
The CDC's Advisory Committee on Immunization Practices voted 6-5 Wednesday to add a booster dose of the meningitis vaccine at age 16. Reuters notes that health officials want to address waning
